3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid

3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid Suppliers list
Company Name: ChemPep, Inc.  
Tel: +1 (888) 615-9178 / (561) 791-8787
Email: service@chempep.com
Company Name: T&W GROUP  
Tel: 021-61551611 13296011611
Email: contact@trustwe.com
Company Name: Nanjing Norris-Pharm Technology Co., Ltd  
Tel: 13901585132
Email: sales@norris-pharm.com
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Company Name: Amatek Scientific Co. Ltd.  
Tel: 0512-56316828 400-867-5858;400-867-5858
Email: info@amateksci.com

3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid manufacturers

  • m-PEG9-CH2COOH
  • m-PEG9-CH2COOH pictures
  • $35.00
  • 2026-08-08
  • CAS:405518-55-0
  • Purity: 99.76%
  • Supply Ability: 10g
3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid Basic information
Product Name:3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid
Synonyms:3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid;MPEG9-CH2COOH;mPEG9-acetic acid;2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]acetic acid;PROTAC Linkers,mPEG9CH2COOH,inhibit,m PEG9 CH2COOH,m-PEG-9-CH2COOH,Inhibitor;mPEG9-CH2COOH/3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid;2,5,8,11,14,17,20,23,26,29-decaoxahentriacontan-31-oic acid
CAS:405518-55-0
MF:C21H42O12
MW:486.55
EINECS:
Product Categories:
Mol File:405518-55-0.mol
3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid Structure
3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid Chemical Properties
Boiling point 557.4±45.0 °C(Predicted)
density 1.122
form Liquid
pka3.39±0.10(Predicted)
color Colorless to light yellow
Safety Information
MSDS Information
3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid Usage And Synthesis
Usesm-PEG9-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].
IC 50PEGs
References[1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005
3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid Preparation Products And Raw materials
Raw materialsNonaethylene Glycol Monomethyl Ether
Tag:3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid(405518-55-0) Related Product Information
3,6,9,1,15,18,21,24-Octaoxahexacosane-1-26-diaMi m-PEG10-Mal m-PEG10-Ph-CHO 2,5,8,11,14,17,20,23,26,29-Decaoxahentriacontane-31-thiol [[p-(2-methoxyethyl)phenoxy]methyl]oxirane m-PEG10-acid 3,6,9,12,15,18,21,24,27,30,33-Undecaoxatetratriacontanoic acid mPEG4-Hydrazide m-PEG4-Hydrazide 3,6,9,12,15,18,21,24,27-Nonaoxaoctacosanoic acid MPEG12-Hydrazide MPEG5-Hydrazide MPEG24-Hydrazide MPEG8-Hydrazide MPEG6-Hydrazide MPEG16-Hydrazide MPEG36-Hydrazide m-PEG10-CHO